MYCN and neuroblastoma: N-myc-amplified NB cells may become enriched with a CSC-like sub-population after long term drug selection with doxorubicin. Treatment with intermittent low doses of vorinostat downregulates stemness gene expression and sensitizes the drug-resistant cells.